Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Attention Bias Modification Treatment (ABMT)
- Sponsor
- Tel Aviv University
- Enrollment
- 52
- Locations
- 1
- Primary Endpoint
- Clinician-Administered PTSD Scale (CAPS)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Patients with Post Traumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to normalize threat-related attention biases or a placebo control condition not designed to change attention patterns. Outcome measures will be Post Traumatic Stress Disorder (PTSD), depression, and anxiety symptoms as measured by gold standard questionnaires and symptom counts derived from structured clinical interviews.
We expect to see significant Post Traumatic Stress Disorder symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected.
Investigators
Yair Bar-Haim
Professor
Tel Aviv University
Eligibility Criteria
Inclusion Criteria
- •Combat-related PTSD diagnosis
Exclusion Criteria
- •Other treatment
Outcomes
Primary Outcomes
Clinician-Administered PTSD Scale (CAPS)
Time Frame: 40 minutes
The clinician-Administered PTSD Scale (CAPS) is a 30-item structured interview that corresponds to the DSM-IV criteria for PTSD (Blake, Weathers, Nagy, Kaloupek, Charney, \& Keane, 1995).
Secondary Outcomes
- PTSD Check List (PCL)(10 minutes)